We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+10.25%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$11.1B
AUM Growth
+$741M
Cap. Flow
+$44.8M
Cap. Flow %
0.4%
Top 10 Hldgs %
46.19%
Holding
644
New
123
Increased
182
Reduced
176
Closed
131

Sector Composition

Rank Sector Weight
1 Financials 34.54%
2 Energy 15.99%
3 Industrials 10.74%
4 Materials 9.81%
5 Communication Services 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MU icon
251
Micron Technology
MU
$1.03T
$1.18M 0.01%
65,800
-12,200
-16% -$177K
TRIP icon
252
TripAdvisor
TRIP
$1.26B
$1.17M 0.01%
+15,000
New +$1.06M
STT icon
253
State Street
STT
$52.2B
$1.14M 0.01%
16,900
+1,700
+11% +$116K
AEGR
254
DELISTED
Aegerion Pharmaceuticals
AEGR
$1.11M 0.01%
12,650
-1,900
-13% -$161K
TWC
255
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$1.11M 0.01%
9,650
-900
-9% -$101K
UFS
256
DELISTED
DOMTAR CORPORATION (New)
UFS
$1.1M 0.01%
+26,960
New +$958K
RGEN icon
257
Repligen
RGEN
$9.35B
$1.1M 0.01%
96,200
+15,600
+19% +$155K
SD
258
DELISTED
SANDRIDGE ENERGY, INC.
SD
$1.09M 0.01%
+180,300
New +$967K
SNY icon
259
Sanofi
SNY
$105B
$1.08M 0.01%
+20,748
New +$1.06M
HHS icon
260
Harte-Hanks
HHS
$18.6M
$1.08M 0.01%
11,884
+1,950
+20% +$178K
VRTX icon
261
Vertex Pharmaceuticals
VRTX
$133B
$1.08M 0.01%
+13,850
New +$1.1M
AET
262
DELISTED
Aetna Inc
AET
$1.08M 0.01%
16,350
+3,400
+26% +$218K
NBIX icon
263
Neurocrine Biosciences
NBIX
$15.9B
$1.07M 0.01%
92,300
+67,300
+269% +$925K
CAJ
264
DELISTED
Canon, Inc.
CAJ
$1.07M 0.01%
+32,627
New +$1.05M
AVTA
265
DELISTED
Avantax, Inc. Common Stock
AVTA
$1.07M 0.01%
45,400
+5,800
+15% +$121K
CTCT
266
DELISTED
CONSTANT CONTACT, INC COM
CTCT
$1.03M 0.01%
+42,300
New +$805K
CNO icon
267
CNO Financial Group
CNO
$5.02B
$1.03M 0.01%
69,300
-74,695
-52% -$1.06M
RATE
268
DELISTED
Bankrate Inc
RATE
$1.02M 0.01%
48,300
+27,200
+129% +$467K
LGND icon
269
Ligand Pharmaceuticals
LGND
$5.85B
$1.01M 0.01%
36,388
+6,252
+21% +$176K
SFLY
270
DELISTED
Shutterfly, Inc.
SFLY
$985K 0.01%
17,150
+12,300
+254% +$684K
BGG
271
DELISTED
Briggs & Stratton Corp.
BGG
$983K 0.01%
+47,550
New +$959K
STX icon
272
Seagate
STX
$199B
$981K 0.01%
21,800
-13,500
-38% -$567K
GOOG icon
273
Alphabet (Google) Class C
GOOG
$4.19T
$945K 0.01%
42,157
-82,308
-66% -$1.82M
NYT icon
274
New York Times
NYT
$10.3B
$943K 0.01%
73,000
-136,339
-65% -$1.61M
SCLN
275
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$932K 0.01%
178,900
+5,700
+3% +$31.7K

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q3 2013 Portfolio in Review

As of Q3 2013, Connor, Clark & Lunn Investment Management (CC&L) held 644 positions worth $11.1B, up 7.1% from $10.4B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L)'s Q3 2013 filing shows 123 new, 182 increased, 176 reduced and 131 closed positions. Its largest new stake was Eldorado Gold: 808,715 shares worth $28.1M. The largest sale was Cenovus Energy, an estimated $96.3M.

By sector, the portfolio is most concentrated in Financials at 35% of assets, up from 34% a quarter earlier, followed by Energy and Industrials.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q3 2013 buy was Eldorado Gold: 808,715 shares worth $28.1M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Canadian Natural Resources in Q3 2013, an estimated $73.1M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q3 2013 reduction was Cenovus Energy, cutting an estimated $96.3M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Vanguard FTSE Emerging Markets ETF in Q3 2013, selling an estimated $17M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 46% of its $11.1B portfolio in Q3 2013.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 123 new positions and closed 131 in Q3 2013.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 7.1% quarter-over-quarter to $11.1B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2013, filed 14 Nov 2013.